Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists

被引：162

作者：

Lange, JHM ^{[1
]}

Kruse, CG ^{[1
]}

机构：

[1] Solvay Pharmaceut, Res Labs, NL-1381 CP Weesp, Netherlands

来源：

DRUG DISCOVERY TODAY | 2005年 / 10卷 / 10期

关键词：

D O I：

10.1016/S1359-6446(05)03427-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The proven clinical efficacy of the CB1 cannabinoid receptor antagonist rimonabant in both obesity and smoking cessation and its therapeutic potential in other disorders has given a tremendous impetus to the discovery of novel CB1 antagonists. The number of disclosed patents wherein novel chemical entities having CB1 antagonistic or inverse agonistic properties have been claimed has exploded. Besides novel compound classes that were identified in screening, rational medicinal chemistry approaches such as conformational constraint and scaffold hopping have been successfully applied. CB1 receptor modelling has provided insight into crucial receptor-ligand interaction points thereby leading to a general CB, inverse agonist pharmacophore model.

引用

页码：693 / 702

页数：10

共 107 条

[1]

Adam J, 2002, EXPERT OPIN THER PAT, V12, P1475

[2]

Adams IB, 1996, ADDICTION, V91, P1585, DOI 10.1111/j.1360-0443.1996.tb02264.x

[3] Membrane assembly of the cannabinoid receptor 1: Impact of a long N-terminal tail [J].

Andersson, H ;

D'Antona, AM ;

Kendall, DA ;

Von Heijne, G ;

Chin, CN .

MOLECULAR PHARMACOLOGY, 2003, 64 (03) :570-577

[4]

Bab I., 2004, PCT Int. Appl., WO, Patent No. [2004 103410, 2004103410]

[5] Cannabinoids control spasticity and tremor in a multiple sclerosis model [J].

Baker, D ;

Pryce, G ;

Croxford, JL ;

Brown, P ;

Pertwee, RG ;

Huffman, JW ;

Layward, L .

NATURE, 2000, 404 (6773) :84-87

[6]

Baker R. K., 2005, WO Patent, Patent No. 2005000809

[7]

Barth F, 1999, CURR MED CHEM, V6, P745

[8] SR-141716A-induced stimulation of locomotor activity - A structure-activity relationship study [J].

Bass, CE ;

Griffin, G ;

Grier, M ;

Mahadevan, A ;

Razdan, RK ;

Martin, BR .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 74 (01) :31-40

[9] Endocannabinoids acting at vascular CB, receptors mediate the vasodilated state in advanced liver cirrhosis [J].

Bátkai, S ;

Járat, Z ;

Wagner, JA ;

Goparaju, SK ;

Varga, K ;

Liu, J ;

Wang, L ;

Mirshahi, F ;

Khanolkar, AD ;

Makriyannis, A ;

Urbaschek, R ;

Garcia, N ;

Sanyal, AJ ;

Kunos, G .

NATURE MEDICINE, 2001, 7 (07) :827-832

[10] G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current [J].

Begg, M ;

Mo, FM ;

Offertáler, L ;

Bátkai, S ;

Pacher, P ;

Razdan, RK ;

Lovinger, DM ;

Kunos, G .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (46) :46188-46194

← 1 2 3 4 5 6 7 8 9 10 →